News

Shares of the newly branded ETHZilla Corp. (NASDAQ:ETHZ) sank over 4% in Monday's after-hours trading amid a dip in Ethereum ...
Life Sciences Corp. (NASDAQ:ATNF) shares slid 1.45% in after-hours trading on Thursday, coinciding with the decline of the ...
ETHZILLA (180 Life Sciences) pivots to an Ethereum treasury strategy, holding 82,186 ETH. Stock surged 312% in a year. Learn ...
Company Initiates Institutional ETH Accumulation Strategy PALO ALTO, Calif., Aug. 12, 2025 /PRNewswire/ -- 180 Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla ...
Life Sciences Corp. (NASDAQ:ATNF), now operating under the name ETHZilla, experienced a sharp 75% increase in its stock price ...
Life Sciences Corp. rebrands to ETHZilla, pivots to Ethereum treasury with 82K ETH holdings. Click for my take on ATNF stock following these developments.
Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or "ETHZilla"), announced today that is has total holdings of 82,186 Ether ("ETH") at an average acquisition price ...
Life Sciences Corp (NASDAQ:ATNF) stock fell 25% following the company’s announcement of a sales agreement that could see up ...
--180 Life Sciences Corp. is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez has significant experience in the ...
AMD (AMD) stock is jumping to its highest level since July, days after the company made a deal with the White House on ...
180 Life Sciences Corp. is a clinical stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing ...
At the moment, 180 Life Sciences doesn't have any drugs of its own in clinical trials. Instead, it has some new method-of-use patents regarding AbbVie 's top-selling anti-inflammatory treatment ...